BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Animate Biosciences Delivers Ai Designed Peptides That Match Standard Of Care In Pulmonary Fibrosis Model

Animate Biosciences announces positive preclinical results from a mouse model of pulmonary fibrosis demonstrating that two of its AI-designed therapeu...

January 15, 2026 | News

Novartis Secures Worldwide Licence To PepLib Peptide Asset To Expand Radioligand Therapy Pipeline

Zonsen PepLib Biotech Inc. announced that it has entered into a worldwide license agreement with Novartis for an undisclosed peptide-based asset in t...

January 15, 2026 | News

Allele Joins Arpa H Programme To Bioprint Patient Specific Livers With Uc San Diego

Allele Biotechnology & Pharmaceuticals, Inc. (Allele), a San Diego-based technology development and cell manufacturing company, announced its par...

January 15, 2026 | News

Aptar Powers Intranasal Covid Vaccine Trial With LuerVax And Spray Divider Delivery Systems

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery and consumer product dosing, dispensing and protection technologies, announced that its inno...

January 15, 2026 | News

TetraScience And Thermo Fisher Join Forces To Accelerate Scientific AI Across Biopharma

TetraScience, the Scientific Data and AI company, announced a collaboration with Thermo Fisher Scientific Inc., the world leader in serving science, with a...

January 14, 2026 | News

Thermo Fisher And NVIDIA Join Forces To Build The AI Powered Laboratory Of The Future

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced a strategic collaboration with NVIDIA to power AI-based solutions...

January 13, 2026 | News

Formosa Pharmaceuticals Secures Strategic Korea Commercial Partner For Its FDA Approved Ophthalmic Therapy

Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced that the company has entered into an exclusive licensing agreement with Sam...

January 13, 2026 | News

FDA Signals A Faster Regulatory Path For Cell And Gene Therapies

The U.S. Food and Drug Administration announced it is sharing information about the agency’s flexible appro...

January 13, 2026 | News

China Approves ArkBio Aizhida For ADHD With Rapid Onset And All Day Symptom Control

Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that China's National Medical Products Administration (NMPA) has approved the...

January 12, 2026 | News

Pierre Fabre Laboratories And Iktos Launch AI Driven Oncology Drug Discovery Alliance

Pierre Fabre Laboratories and Iktos, a global leader in Artificial Intelligence (AI) and Robotics on drug discovery, announced an integrated drug disc...

January 12, 2026 | News

Johnson And Johnson Amivantamab Combo Delivers 73% Response Rate In First Line Metastatic Colorectal Cancer

Over 70 percent of patients in the first-line subgroup responded to amivantamab plus chemotherapy with most responses lasting beyond 16 months Notable res...

January 12, 2026 | News

AirNexis Secures Global Rights To Phase 2 COPD Asset AN01 In $200 Million Series A Backed By Frazier And OrbiMed

AirNexis acquires exclusive rights to develop AN01 outside of China from Haisco Pharmaceutical Group Company founded by Frazier Life Sciences, which led...

January 12, 2026 | News

Biocytogen And Acepodia Advance Dual Payload Bispecific ADC Strategy Through Option Based Licensing Pact

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), announced that the companies have entered int...

January 12, 2026 | News

One Genomics And CiRA Foundation Forge AI Powered Genome Engineering Alliance To Accelerate De Aging Science

AI-Focused Genomics Company Advancing De-Aging Science Collaborates with Leading iPS Cell Manufacturing and Research Foundation One Genomics, an...

January 12, 2026 | News

Stay Connected